- The latest advances in pancreatic cancer research will be presented at a congress organised by Fundación Ramón Areces with CNIO researchers
09.09.2025
Pancreatic cancer is one of the best-known tumours at a molecular level, yet its survival rate remains extremely low. Less than 5% of patients survive for five years following diagnosis. This has to do with late diagnosis, as most cases are detected when the tumour is no longer operable. Furthermore, when it comes to pancreatic […] - CNIO researcher develops a test aimed to detect early-stage tumors with a blood sample
31.07.2025
Current methods for cancer diagnosis are based on identifying biomarkers – molecules that reveal a particular state or process in the body – produced by the tumour or associated proteins. Not surprisingly, these markers are more abundant once the tumour has already developed significantly. And the more advanced the tumour, the more difficult it is […] - CNIO celebrates its Friends’ solidarity, essential to attract talent and advance cancer research
22.07.2025
An important part of the knowledge generated by the National Cancer Research Centre (CNIO), which aims to improve cancer prevention, diagnosis and treatment, is the result of generosity. The generosity of people, companies and foundations that make donations to the centre through the ‘CNIO Friends’ programme. Since it was launched in 2015, all funds raised by this programme have been allocated to recruiting young researchers, a […] - CNIO researchers discover a molecular mechanism that initiates colon cancer
06.05.2025
Colorectal – colon or rectal – cancer is the third most diagnosed type of cancer worldwide. Up to 80% of the cases are related to environmental factors and lifestyle, such as poor diet, sedentarism, obesity, smoking or excessive alcohol consumption. Most colorectal cancers arise from adenomatous polyps, a precancerous lesion that may progress to a […] - The CNIO will use AI to search for mutation patterns which help predict tumor development and response to treatment
16.04.2025
Some tumors are caused by one or more inherited mutations in specific genes. Others are the result of the accumulation, over a lifetime, of mutations induced by environmental factors or lifestyle habits. Over time, research has identified some of these mutations as being directly responsible for causing a tumor. However, there are many other mutations […] - Two new research groups at CNIO thanks to the arrival of the ‘AI Generation’
09.04.2025
The ministry for Digital Transformation and Public Service and the ministry of Science, Innovation and Universities presented the programme ‘Generation D: Building the AI Generation’, which has allowed the National Cancer Research Centre (CNIO) to bring on board two new research groups and fourteen researchers. They all share the ability to use Artificial Intelligence as […] - CNIO research reveals how melanoma and other tumours succeed in hiding and resisting immunotherapy
28.03.2025
Cutaneous melanoma, the most aggressive form of skin cancer, is characterised by its accumulation of a large number of mutations. Although some of these alterations should be recognised as a threat by our defences, melanomas often escape immune system surveillance. As a result, more than half of patients do not generally respond to current immunotherapies. […] - CNIO researchers discover a new mechanism for rapid liver regeneration triggered by glutamate
26.03.2025
The liver is a vital organ, crucial to digestion, metabolism and the elimination of toxins. It has a unique ability, regeneration, which allows it to replace liver cells damaged by the very toxins that these cells eliminate. However, the liver stops regenerating in cases of diseases that involve chronic liver damage –such as cirrhosis–. Such […] - Curing cancer? Research is where it all begins
25.03.2025
At the Spanish National Cancer Research Center, the CNIO, we do research to learn how to reduce the risk of cancer; detect it as early as possible; and treat it effectively. We know that it is not easy, and that we will come forward little by little. But we are convinced that our work, research, […]